Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

PHASE3CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Non-Hodgkin's LymphomaLymphoma

Interventions

DRUG

Zoledronic Acid

4 mg/m\^2 by vein over 30 Minutes at baseline and 6 months.

DRUG

Vitamin D

400 mg by mouth daily

DRUG

Calcium Carbonate

1200 mg by mouth daily

Trial Locations (1)

UT MD Anderson Cancer Center, Houston